Exacerbations and Real-World Outcomes After Single-Inhaler Triple Therapy of Budesonide/Glycopyrrolate/Formoterol Fumarate, Among Patients with COPD: Results from the EROS (US) Study

PURPOSE: Triple therapy to prevent exacerbations from chronic obstructive pulmonary disease (COPD) is associated with improved health compared to single and dual-agent therapy in some populations. This study assessed the benefits of prompt administration of budesonide/glycopyrrolate/formoterol fumar...

Descripción completa

Detalles Bibliográficos
Autores principales: Strange, Charlie, Tkacz, Joseph, Schinkel, Jill, Lewing, Benjamin, Agatep, Barnabie, Swisher, Sean, Patel, Sushma, Edwards, Devechio, Touchette, Daniel R, Portillo, Edward, Feigler, Norbert, Pollack, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577086/
https://www.ncbi.nlm.nih.gov/pubmed/37849918
http://dx.doi.org/10.2147/COPD.S432963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10577086/
https://www.ncbi.nlm.nih.gov/pubmed/37849918
http://dx.doi.org/10.2147/COPD.S432963

Ejemplares similares